Literature DB >> 16906589

Manifestations of West Nile neuroinvasive disease.

James J Sejvar1, Anthony A Marfin.   

Abstract

Since its introduction to North America in 1999, West Nile virus, an arthropod-borne flavivirus, has become the most significant cause of epidemic encephalitis in the western hemisphere. While most human infections with the virus are asymptomatic and the majority of symptomatic persons experience febrile illness, severe neurologic manifestations, including meningitis, encephalitis, and poliomyelitis may be seen. This review summarizes the virology, epidemiology and pathogenesis of human infection with West Nile virus, and details recent advances in our understanding of the pathophysiology and various clinical manifestations of infection.

Entities:  

Mesh:

Year:  2006        PMID: 16906589     DOI: 10.1002/rmv.501

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  34 in total

1.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

2.  Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

Authors:  John H Beigel; Jeffrey L Nordstrom; Stanley R Pillemer; Cory Roncal; D Ronald Goldwater; Hua Li; P Chris Holland; Syd Johnson; Kathryn Stein; Scott Koenig
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 3.  Emerging viral infections of the central nervous system: part 1.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-08

4.  West Nile virus and the 2012 outbreak: The Baylor University Medical Center experience.

Authors:  Adan Mora; Mariangeli Arroyo; Kyle L Gummelt; Gates Colbert; Anna L Ursales; Michael J Van Vrancken; George J Snipes; Joseph M Guileyardo; Cristie Columbus
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

5.  Myelopathy in West Nile virus encephalitis: Report of a case and review of literature.

Authors:  Jayantee Kalita; Amar Vibhute; Mritunjai Kumar; Usha K Misra
Journal:  J Spinal Cord Med       Date:  2018-08-20       Impact factor: 1.985

Review 6.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

7.  Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico.

Authors:  María de Lourdes Garza Rodríguez; Diana R Rodríguez Rodriguez; Bradley J Blitvich; Miguel A Reyes López; Ildefonso Fernández-Salas; Javier Ramos Jimenez; José A Farfán-Ale; Rogelio Cazares Tamez; César Martinez Longoria; Maria I Tavitas Aguilar; Ana Maria Rivas-Estilla
Journal:  Vector Borne Zoonotic Dis       Date:  2010-03       Impact factor: 2.133

8.  Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.

Authors:  Yoko Kitai; Mizue Shoda; Takashi Kondo; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

9.  West Nile Virus Encephalitis: The First Human Case Recorded in Brazil.

Authors:  Marcelo A C S Vieira; Alessandro P M Romano; Amaríles S Borba; Eliana V P Silva; Jannifer O Chiang; Kelsen D Eulálio; Raimunda S S Azevedo; Sueli G Rodrigues; Walfrido S Almeida-Neto; Pedro F C Vasconcelos
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

10.  Initial and long-term costs of patients hospitalized with West Nile virus disease.

Authors:  J Erin Staples; Manjunath B Shankar; James J Sejvar; Martin I Meltzer; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.